See More Hear More Watch More Hear More Get on iTunes
WSJ Daily Minute WSJMinute

Single-pill Hepatitis C Drug Created

Gilead Sciences got approval to sell its new drug, Harvoni, which is the first pill that promises to cure hepatitis C without requiring the help of other medicines. Taken once a day for a course of 12 weeks, the cost will likely amount to $94,500.


More from